Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical Oncology10-year review of health insurance data set reveals possible protective effect of H1 antihistamines in preventing hepatic cancer

Antihistamine use in patients with HBV, HCV, or dual virus infections was associated with approximately two-fold lower risk of HCC when compared with patients who did not use antihistamines, in a dose-dependent manner.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form